Posted by ABMN Staff on Apr 19th, 2024
Johnson & Johnson (NYSE:JNJ – Get Free Report) had its price target reduced by equities research analysts at Morgan Stanley from $168.00 to $167.00 in a research note issued to investors on Wednesday, Benzinga reports....
More of this article »